---
schema_version: "secwatch.filing_event.v1"
accession: "0000096943-24-000146"
form_type: "8-K"
ticker: "TFX"
cik: "0000096943"
company_name: "TELEFLEX INC"
filed_at: "2024-10-31T23:59:59+00:00"
generated_at: "2026-05-30T07:55:03.035223+00:00"
event_type: "earnings"
sentiment: "negative"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Teleflex Q3 GAAP EPS $2.36, adj $3.49; cuts FY revenue growth guidance to 2.9-3.4%

## Summary
- Q3 GAAP revenue $764.4M, +2.4% YoY; GAAP diluted EPS $2.36 vs $2.91; adjusted diluted EPS $3.49 vs $3.64.
- Lowers FY2024 GAAP revenue growth guidance to 2.90%-3.40% (from 3.40%-4.40%); adjusted constant currency growth guidance cut to 3.5%-4.0%.
- Raises FY2024 GAAP EPS guidance to $6.65-$6.95 (from $6.43-$6.83); adjusted EPS guidance $13.90-$14.20.
- Interventional Urology (+13.3%) and Interventional (+11.8%) drove growth; OEM soft at +0.3%; Other category fell 28% due to Italian payback reserve.
- Board authorized $500M share repurchase; $200M accelerated share program in Q3; net leverage 1.7x.

## SEC filing metadata
- accession: 0000096943-24-000146
- form_type: 8-K
- ticker: TFX
- cik: 0000096943
- company_name: TELEFLEX INC
- filed_at: 2024-10-31T23:59:59+00:00
- event_type: earnings
- sentiment: negative
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 2.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/96943/000009694324000146/0000096943-24-000146-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/96943/000009694324000146/tfx-20241031.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000096943-24-000146
- JSON: https://secwatch.observer/filing/0000096943-24-000146.json
- Plain text: https://secwatch.observer/filing/0000096943-24-000146.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.